Form 4 for IMDX Insight Molecular Diagnostics Inc.

Accepted 2025-01-15 00:00:00 ET · period of report 2025-01-13 · accession 0001493152-25-002410 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2025-01-15	2025-01-13+	IMDX	SMITH PATRICK W	10%	P - Purchase	$2.12	+16.1K	1.79M	+0.9%	+$34.1K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, no par value	2025-01-13	P	A	5,669	$2.08	1,779,572	I See footnote	—	—	(F1) The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.
2	Common	Common Stock, no par value	2025-01-14	P	A	100	$2.08	1,779,672	I See footnote	—	—	(F1) The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.
3	Common	Common Stock, no par value	2025-01-14	P	A	10,286	$2.15	1,789,958	I See footnote	—	—	(F1) The shares of common stock reported herein are directly held by PATRICK W SMITH TTEE THE SMITH IRREVOCABLE TRUST U/A DTD 05/01/2015 (the "Trust"). As the trustee of the Trust, the Reporting Person may be deemed to beneficially own the securities held by the Trust.